The recent ACR and SHARE guidance for management of JIA associated uveitis recommends addition of anti-TNF for control of JIA-associated uveitis, which is refractory to methotrexate [9, 10]. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.